-
AMAG Pharmaceuticals: Q1 Earnings Insights
11 May 2020 12:09 GMT
Shares of AMAG Pharmaceuticals (NASDAQ:AMAG) remained … the company for now.
AMAG Pharmaceuticals hasn't issued … 19.25%
Company Profile
AMAG Pharmaceuticals Inc primarily uses its … that assist in identifying cancerous tumors. The company recently …
-
AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer
28 Apr 2020 11:00 GMT
… 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today … company focused on metastatic bladder cancer. Prior to joining Rainier, … ‐looking statements. AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. AMAG …
-
AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial
29 Oct 2019 11:03 GMT
… , 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) … problems, breast cancer or other hormone-sensitive cancers, or history … com. AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals Contact: …
-
AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of Perinatology
25 Oct 2019 14:19 GMT
… . 25, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced … clotting problems, breast cancer or other hormone-sensitive cancers, or history of … in the forward-looking statements. AMAG Pharmaceuticals® and the logo are registered …
-
Bringing AMAG Pharmaceuticals Back To Life
22 Oct 2019 15:38 GMT
… that, under the right circumstances, AMAG pharmaceuticals' (AMAG) shares could … value of AMAG Company background AMAG pharmaceuticals was incorporated in 1981. The … maternal health, anemia management, and cancer supportive care. AMAG products include …
-
AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP
08 Oct 2019 12:00 GMT
… as Chair of the American Cancer Society Initiative for New England … (CEOs against Cancer) and as a Special Advisor … www.amagpharma.com. AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. Forward …
-
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi™ (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
21 Jun 2019 21:23 GMT
… 21, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced … trademarks of AMAG Pharmaceuticals, Inc. Vyleesi™ is a trademark of AMAG Pharmaceuticals, Inc. … other emotional stimuli in breast cancer survivors with and without distress …
-
AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
07 May 2019 11:00 GMT
… clotting problems, breast cancer or other hormone-sensitive cancers, or history of … with a history of breast cancer. In clinical studies, vaginal … trademarks of AMAG Pharmaceuticals, Inc. VyleesiTM is a trademark of AMAG Pharmaceuticals, Inc. Makena …
-
AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena® (hydroxyprogesterone caproate injection)
08 Mar 2019 13:00 GMT
… problems, breast cancer or other hormone-sensitive cancers, or history … contains forward-looking information about AMAG Pharmaceuticals, Inc. within the … looking statements. AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. Makena …
-
AMAG Pharmaceuticals Inc (AMAG) Files 10-K for the Fiscal Year Ended on December 31, 2018
01 Mar 2019 22:00 GMT
… ended on December 31, 2018. AMAG Pharmaceuticals Inc is a biopharmaceutical company … aid in the diagnosis of cancer. AMAG Pharmaceuticals Inc has a market cap … million in the previous year. AMAG Pharmaceuticals Inc has a financial strength …
About
© 1995-2025